You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
Speaker | Nadia Ashrafi, Ph.D.
Affiliation | Metabolomics Research Group | Corewell Health Research Institute | Corewell Health East William Beaumont University Hospital | Research Scientist
Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson’s disease
Part of the
Corewell Health Metabolomics Symposium
Comprehensive metabolomic profiling of the LRRK2 Cohort Consortium (LCC) identifies prodromal biomarkers for Parkinson’s Disease
Related articles
- Nicotinic acid – From vitamin B3 to precision metabolism
- Exposomics and Metabolomics | The dynamic duo of the post-genomic era
- Eicosapentaenoic acid (EPA) – Anti-inflammatory lipid mediator
- Immunotherapy response | Metabolomics accelerating 5P medicine
- Biognosys Group at AZ Metabolomics & T32 Symposium
